日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Investigation of factors associated with reduced clinical benefits of personalized peptide vaccination for pancreatic cancer

探讨与胰腺癌个性化肽疫苗临床疗效降低相关的因素

Uchino, Yoshihiro; Muroya, Daisuke; Yoshitomi, Munehiro; Shichijo, Shigeki; Yamada, Akira; Sasada, Tetsuro; Yamada, Teppei; Okuda, Koji; Itoh, Kyogo; Yutani, Shigeru

Plasma level of prostate related-antigen peptide-reactive IgG is a prognostic factor of patients with breast cancer treated with personalized peptide vaccines

血浆中前列腺相关抗原肽反应性IgG水平是接受个性化肽疫苗治疗的乳腺癌患者的预后因素。

Saku, Shuko; Toh, Uhi; Takao, Yuko; Sakurai, Sayaka; Yamada, Akira; Shichijo, Shigeki; Itoh, Kyogo; Akagi, Yoshito

Mixed 20-peptide cancer vaccine in combination with docetaxel and dexamethasone for castration-resistant prostate cancer: a randomized phase II trial

混合20肽癌症疫苗联合多西他赛和地塞米松治疗去势抵抗性前列腺癌:一项随机II期试验

Noguchi, Masanori; Arai, Gaku; Egawa, Shin; Ohyama, Chikara; Naito, Seiji; Matsumoto, Kazumasa; Uemura, Hirotsugu; Nakagawa, Masayuki; Nasu, Yasutomo; Eto, Masatoshi; Suekane, Shigetaka; Sasada, Tetsuro; Shichijo, Shigeki; Yamada, Akira; Kakuma, Tatsuyuki; Itoh, Kyogo

Early phase II study of mixed 19-peptide vaccine monotherapy for refractory triple-negative breast cancer

针对难治性三阴性乳腺癌的混合19肽疫苗单药疗法的早期II期研究

Toh, Uhi; Sakurai, Sayaka; Saku, Shuko; Takao, Yuko; Okabe, Mina; Iwakuma, Nobutaka; Shichijo, Shigeki; Yamada, Akira; Itoh, Kyogo; Akagi, Yoshito

A randomized, double-blind, phase III trial of personalized peptide vaccination for recurrent glioblastoma

一项针对复发性胶质母细胞瘤的个性化肽疫苗随机、双盲、III期临床试验

Narita, Yoshitaka; Arakawa, Yoshiki; Yamasaki, Fumiyuki; Nishikawa, Ryo; Aoki, Tomokazu; Kanamori, Masayuki; Nagane, Motoo; Kumabe, Toshihiro; Hirose, Yuichi; Ichikawa, Tomotsugu; Kobayashi, Hiroyuki; Fujimaki, Takamitsu; Goto, Hisaharu; Takeshima, Hideo; Ueba, Tetsuya; Abe, Hiroshi; Tamiya, Takashi; Sonoda, Yukihiko; Natsume, Atsushi; Kakuma, Tatsuyuki; Sugita, Yasuo; Komatsu, Nobukazu; Yamada, Akira; Sasada, Tetsuro; Matsueda, Satoko; Shichijo, Shigeki; Itoh, Kyogo; Terasaki, Mizuhiko

Antitumor activity of antibody against cytotoxic T lymphocyte epitope peptide of lymphocyte-specific protein tyrosine kinase

针对淋巴细胞特异性蛋白酪氨酸激酶的细胞毒性T淋巴细胞表位肽的抗体的抗肿瘤活性

Matsueda, Satoko; Itoh, Kyogo; Shichijo, Shigeki

Survival analysis of multiple peptide vaccination for the selection of correlated peptides in urological cancers

针对泌尿系统癌症,通过多肽疫苗接种筛选相关肽段,进行生存分析

Noguchi, Masanori; Koga, Noriko; Moriya, Fukuko; Suekane, Shigetaka; Yutani, Shigeru; Yamada, Akira; Shichijo, Shigeki; Kakuma, Tatuyuki; Itoh, Kyogo

Immunological evaluation of peptide vaccination for cancer patients with the HLA -A11(+) or -A33(+) allele

对携带 HLA -A11(+) 或 -A33(+) 等位基因的癌症患者进行肽疫苗免疫学评估

Sakamoto, Shinjiro; Matsueda, Satoko; Takamori, Shinzo; Toh, Uhi; Noguchi, Masanori; Yutani, Shigeru; Yamada, Akira; Shichijo, Shigeki; Yamada, Teppei; Suekane, Shigetaka; Kawano, Kouichiro; Naitou, Masayasu; Sasada, Tetsuro; Hattori, Noboru; Kohno, Nobuoki; Itoh, Kyogo

Feasibility study of personalized peptide vaccination for hepatocellular carcinoma patients refractory to locoregional therapies

对局部区域治疗无效的肝细胞癌患者进行个性化肽疫苗接种的可行性研究

Yutani, Shigeru; Shirahama, Takahisa; Muroya, Daisuke; Matsueda, Satoko; Yamaguchi, Rin; Morita, Michi; Shichijo, Shigeki; Yamada, Akira; Sasada, Tetsuro; Itoh, Kyogo

Personalized peptide vaccination as second-line treatment for metastatic upper tract urothelial carcinoma

个性化肽疫苗作为转移性上尿路尿路上皮癌的二线治疗

Suekane, Shigetaka; Ueda, Kousuke; Nishihara, Kiyoaki; Sasada, Tetsuro; Yamashita, Takuto; Koga, Noriko; Yutani, Shigeru; Shichijo, Shigeki; Itoh, Kyogo; Igawa, Tsukasa; Noguchi, Masanori